Skye Bioscience Inc (SKYE)

[AntonChigurh]

90% eh Vinpat?

Some heavy hitters on that list, you must have some connections.

The first few PIPE's were at $5 a share, so I have to agree with Vinpat that some will be holding until it goes boom (or bust). Although more recent ones have been sub-dollar.

Speaking of Bust, Vinpat can you help me with Patent info? I want to know, of the UM licenses Nemus has, what has patents, provisional patents or pending ones.

Here is what I can find so far:

http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=2&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=52&f=G&l=50&d=PTXT&S1=Elsohly&OS=Elsohly&RS=Elsohly

http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=7&f=G&l=50&d=PTXT&S1=Elsohly&OS=Elsohly&RS=Elsohly

http://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PG01&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.html&r=1&f=G&l=50&s1=%2220060257463%22.PGNR.&OS=DN/20060257463&RS=DN/20060257463

http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=6365416.PN.&OS=PN/6365416&RS=PN/6365416

According to myself, Nemus has licensed the following molecules from UMiss:

UM5050 (main THC prodrug)
UM1490 (delivery systems)
UM5070 (MRSA)
UM8790 (ocular delivery)
UM8930 (CBD pro-drug, CIPN) although I thought I read their CBD drug was a 'analogue'

Most of those licensing deals were signed before Nemus did their RTO, so I can't get access to the contracts. I did for UM8930 deal:

https://www.sec.gov/Archives/edgar/data/1516551/000164033415000467/ex-10_1.htm

Under Patents it says:

'Pending filing of a provisional patent application. Working Title: “Cannabidiol prodrugs with improved bioavailability”.'

I am just wondering where to look and who I should ask for this info. Reasoning being, in the WORST CASE SCENARIO, if Nemus was unable to get their indications through FDA approval process, I still think their UM license's would be of value to someone (depending on the sectors landscape).

So I want to know what exactly has been granted patents, what has been applied for, etc.

It Nemus has properly secured this IP for the next 5-20 years, I feel this is still not being accurately priced. Liquidating those licenses with the current share structure, fully diluted, would still reward shareholders who are purchasing stock at this price. I am probably wrong though, I often am :P

DYODD GLTFA